To test the safety and effectiveness of AZD6244 in older children and young adults who have gliomas that have not responded to standard treatments.
Study Type: Interventional
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
AGES ELIGIBLE FOR STUDY: 12 Years to 21 Years
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2018 Cincinnati Children's Hospital Medical Center. All rights reserved.